Tag

treatment- Pagina 2

5 minuti di lettura

Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS

(Adnkronos) – APDS (activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome) is a rare and progressive primary immunodeficiency Joenja® is a targeted treatment of APDS for adult and pediatric patients 12 years of age

Immediapress

Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease

(Adnkronos) – TAMPA, Fla., Feb. 13, 2023 /PRNewswire/ — Concept Medical Inc. (CMI), on 9thFebruary 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch Sirolimus Coated Balloon. The Magic Touch PTA Sirolimus Coated Balloon Catheter is

Investigational study provides evidence that recombinant endolysin XZ.700* is a promising novel non-antibiotic treatment strategy aimed at controlling Staphylococcus aureus (S. aureus) colonization of lesional skin in Cutaneous T-cell lymphoma (CTCL).

Immediapress

(Adnkronos) – Research shows XZ.700* could block tumor promoting effects of S. aureus on malignant T cells, potentially delaying tumor progression. Findings strengthen potential

Servier receives European Commission approval of Tibsovo® (ivosidenib tablets) in IDH1-mutated Acute Myeloid Leukemia and IDH1-mutated Cholangiocarcinoma

Immediapress

(Adnkronos) – PARIS, May 10, 2023/PRNewswire/ — Servier, a global pharmaceutical group, today announced that the European Commission (EC) has approved Tibsovo® (ivosidenib tablets)

Race executes global license agreement with City of Hope to access FTO IP

lunedì, 10 Luglio 2023

Immediapress

(Adnkronos) – SYDNEY, July 10, 2023 /PRNewswire/ — Race Oncology Limited (“Race”) is pleased to announce execution of an exclusive licence agreement (“Agreement”) to access U.S. cancer research and treatment organisation City of

European Commission Grants Conditional Marketing Authorization for Taiho’s LYTGOBI® Tablets for the Treatment of Adults With Cholangiocarcinoma

martedì, 4 Luglio 2023

Immediapress

(Adnkronos) – LYTGOBI is the first irreversibly binding FGFR inhibitor in the European Union for use in the treatment of patients with cholangiocarcinoma ZUG, Switzerland, July 4, 2023 /PRNewswire/ — Taiho Oncology

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

lunedì, 29 Maggio 2023

Immediapress

(Adnkronos) – TAMPA, Fla., May 29, 2023 /PRNewswire/ — The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s Sirolimus Coated Balloon (SCB)

Tianlong Helps Hospitals in Thailand Detect Hepatitis Early with Molecular Diagnostic Solution

giovedì, 25 Maggio 2023

Immediapress

(Adnkronos) – XI’AN, China, May 25, 2023 /PRNewswire/ — Tianlong, an innovative high-tech company specializing in molecular diagnostic products in China, has partnered with public hospitals in northern Thailand to build up

New Expert Guidelines from IWGDF Highlight the Growing International Recognition of Topical Oxygen Therapy for Diabetic Foot Ulcers

mercoledì, 17 Maggio 2023

Immediapress

(Adnkronos) – Evidence-based recommendations support the effective use of TOT in diabetic foot ulcer management, revolutionizing treatment approaches worldwide CAMBRIDGE, England, May 17, 2023 /PRNewswire/ — NATROX® Wound Care, a leading innovator

Indietro 1 2

treatment- Pagina 2

Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS

Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease

Investigational study provides evidence that recombinant endolysin XZ.700* is a promising novel non-antibiotic treatment strategy aimed at controlling Staphylococcus aureus (S. aureus) colonization of lesional skin in Cutaneous T-cell lymphoma (CTCL).

Servier receives European Commission approval of Tibsovo® (ivosidenib tablets) in IDH1-mutated Acute Myeloid Leukemia and IDH1-mutated Cholangiocarcinoma

Race executes global license agreement with City of Hope to access FTO IP

European Commission Grants Conditional Marketing Authorization for Taiho’s LYTGOBI® Tablets for the Treatment of Adults With Cholangiocarcinoma

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

Tianlong Helps Hospitals in Thailand Detect Hepatitis Early with Molecular Diagnostic Solution

New Expert Guidelines from IWGDF Highlight the Growing International Recognition of Topical Oxygen Therapy for Diabetic Foot Ulcers

Primo piano

CdM approva decreto urgente per autotrasporto, agricoltura e pesca. Meloni: “Non tolleriamo intimidazioni” | Video

Il prete che ha mostrato il dito medio ai ragazzi durante i disordini a Milano: «Pentito? No, ho solo risposto»

Italia-Spagna, la sospensione di Schengen non sarà rinnovata

Blocco Tir, governo “sblocca” in Sicilia e Calabria, ma il Golfo di Napoli a rischio isolamento

Dopo gli scontri: cosa prevede il decreto e quali poteri hanno i militari

Sponsor

Suggerimenti

treatment- Pagina 2

Primo piano

Sponsor